ACGT is working onto an integrated approach over Clinical Trials on clinic-Genomics, proposing models for defining the protocols, preparing the ground for vast possibilities for clinicians to assess diagnosis and treatment results against already existing data repositories.
As the number of clinical trials sees a general decline in Europe due to the heavy costs and legal constraints, ACGT can assist oncologists into getting out of isolation, assisting in increasing the number of collaborations between practitioners.
ACGT provides a platform for the patients to enter their data on a daily base so that practitioners can make a daily monitoring. These advances in telemedicine available in the ACGT platform will enhance the capacity of the oncology community in getting further into trials, allowing therefore the patients to receive the most adapted treatments, care and attentions.
We wish you a pleasant reading through the articles.
